Virender K. Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Virender K. Sharma has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
A. Das
1 shared publicationAnanya Das
1 shared publicationAngelo G Coppola
1 shared publicationChristopher D Wells
1 shared publication- Christopher D Wells
Division of Gastroenterology & Hepatology, Mayo Clinic, Scottsdale, AZ 85259, USA
1 shared publication Colin W Howden
1 shared publication
Latest Publications
- 1 August 2009
- Published by Elsevier in Gastroenterology
- Vol. 137 (2) , 434-439
The Future Is Wireless: Advances in Wireless Diagnostic and Therapeutic Technologies in Gastroenterology
- 1 August 2009
- Published by Elsevier in Gastroenterology
- Vol. 137 (2) , 434-439
The Future Is Wireless: Advances in Wireless Diagnostic and Therapeutic Technologies in Gastroenterology
- 27 January 2009
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 104 (2) , 310-317
Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia
The American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked the #1 clinical journal covering gastroenterology and hepatology*, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients. Published with practicing clinicians in mind, the journal aims to be easily accessible, organizing its content by topic, both online and in print. www.amjgastro.com, *2007 Journal Citation Report (Thomson Reuters, 2008)
- 27 January 2009
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 104 (2) , 310-317
Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia
The American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked the #1 clinical journal covering gastroenterology and hepatology*, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients. Published with practicing clinicians in mind, the journal aims to be easily accessible, organizing its content by topic, both online and in print. www.amjgastro.com, *2007 Journal Citation Report (Thomson Reuters, 2008)
- 5 May 2008
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 40 (05) , 380-387
A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system)
Background and study aims: Yearly surveillance endoscopy is carried out for Barrett’s esophagus with low-grade dysplasia (LGD) so that progression to high-grade dysplasia and adenocarcinoma can be detected at the earliest stage. The aim of the study was to assess the long-term safety and effectiveness of circumferential ablation followed by focal ablation (HALO system) for eliminating Barrett’s esophagus and LGD. Patients and methods: Patients with 2 - 6 cm of Barrett’s esophagus with histology demonstrating LGD on their last two sequential endoscopies over the previous 2 years and confirmed by two pathologists were enrolled in this prospective, single-center trial. Circumferential ablation was carried out at baseline and at 4 months (if residual Barrett’s esophagus present). Endoscopy with 4-quadrant biopsies every 1 cm was performed at 1, 3, 6, 12, and 24 months. After 1 year, focal ablation was applied to any visible Barrett’s esophagus or irregularity of the squamocolumnar junction. Patients received lansoprazole 30 mg bid. Complete responses for dysplasia (CR-dysplasia) and intestinal metaplasia (CR-IM) at 2-year follow-up, with complete response defined as “all biopsies negative for dysplasia or intestinal metaplasia” were the main outcomes. Results: Ten patients (nine men, mean age 66.9 years, range 48 - 79) with confirmed LGD (median 4.4 cm, range 3 - 6) underwent circumferential ablation with focal ablation after 1 year as necessary. At 2 years, CR-dysplasia was 100 % and CR-IM was 90 %. There were no strictures or buried intestinal metaplasia at follow-up. Conclusion: A stepwise regimen of circumferential ablation followed by focal ablation appears to eradicate intestinal metaplasia (90 % CR-IM) and dysplasia (100 % CR-dysplasia) at 2-year follow-up in this trial, without stricture formation or buried intestinal metaplasia.
- 5 May 2008
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 40 (05) , 380-387
A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system)
Background and study aims: Yearly surveillance endoscopy is carried out for Barrett’s esophagus with low-grade dysplasia (LGD) so that progression to high-grade dysplasia and adenocarcinoma can be detected at the earliest stage. The aim of the study was to assess the long-term safety and effectiveness of circumferential ablation followed by focal ablation (HALO system) for eliminating Barrett’s esophagus and LGD. Patients and methods: Patients with 2 - 6 cm of Barrett’s esophagus with histology demonstrating LGD on their last two sequential endoscopies over the previous 2 years and confirmed by two pathologists were enrolled in this prospective, single-center trial. Circumferential ablation was carried out at baseline and at 4 months (if residual Barrett’s esophagus present). Endoscopy with 4-quadrant biopsies every 1 cm was performed at 1, 3, 6, 12, and 24 months. After 1 year, focal ablation was applied to any visible Barrett’s esophagus or irregularity of the squamocolumnar junction. Patients received lansoprazole 30 mg bid. Complete responses for dysplasia (CR-dysplasia) and intestinal metaplasia (CR-IM) at 2-year follow-up, with complete response defined as “all biopsies negative for dysplasia or intestinal metaplasia” were the main outcomes. Results: Ten patients (nine men, mean age 66.9 years, range 48 - 79) with confirmed LGD (median 4.4 cm, range 3 - 6) underwent circumferential ablation with focal ablation after 1 year as necessary. At 2 years, CR-dysplasia was 100 % and CR-IM was 90 %. There were no strictures or buried intestinal metaplasia at follow-up. Conclusion: A stepwise regimen of circumferential ablation followed by focal ablation appears to eradicate intestinal metaplasia (90 % CR-IM) and dysplasia (100 % CR-dysplasia) at 2-year follow-up in this trial, without stricture formation or buried intestinal metaplasia.
- 1 October 2007
- Vol. 3 (10) , 777-785
Capsule Endoscopy in the Evaluation of Obscure Gastrointestinal Bleeding
Historically, the evaluation of patients with obscure gastrointestinal bleeding (OGIB) has been often suboptimal, due to the limited ability to adequately image the small bowel. However, over the past several years, significant improvements have been made in small-bowel imaging techniques, both endoscopically and radiologically. Since the introduction of capsule endoscopy (CE) in particular, the diagnostic and therapeutic approaches to OGIB have improved significantly. Capsule-based technology has enabled a more rapid and accurate diagnosis of many small-bowel disorders. Capsule endoscopy is safe and well tolerated. Many prospective comparative studies have shown that the diagnostic yield of CE is superior compared to other endoscopic and radiologic modalities. Numerous other studies have also shown that CE leads to a significant change in management and improved outcomes.
- 1 October 2007
- Vol. 3 (10) , 777-785
Capsule Endoscopy in the Evaluation of Obscure Gastrointestinal Bleeding
Historically, the evaluation of patients with obscure gastrointestinal bleeding (OGIB) has been often suboptimal, due to the limited ability to adequately image the small bowel. However, over the past several years, significant improvements have been made in small-bowel imaging techniques, both endoscopically and radiologically. Since the introduction of capsule endoscopy (CE) in particular, the diagnostic and therapeutic approaches to OGIB have improved significantly. Capsule-based technology has enabled a more rapid and accurate diagnosis of many small-bowel disorders. Capsule endoscopy is safe and well tolerated. Many prospective comparative studies have shown that the diagnostic yield of CE is superior compared to other endoscopic and radiologic modalities. Numerous other studies have also shown that CE leads to a significant change in management and improved outcomes.
- Open Access
- 8 June 2007
- Published by Springer Nature in BMC Gastroenterology
- Vol. 7 (1) , 1-5
Comparison of morning versus afternoon cecal intubation rates
Background: Many factors impacting cecal intubation rates have been examined in detail; however, little information exists regarding the effect of the timing of the procedure. We sought to examine any difference in cecal intubation rates between morning and afternoon colonoscopies and identify factors contributing to a discrepancy. Methods: Retrospective, single-center study comparing cecal intubation rates for colonoscopies performed in the morning (begun prior to 12 noon) and colonoscopies performed in the afternoon (begun after 12 noon) over an approximately 12 month period. Univariate and multivariate analyses were performed evaluating patient demographics, procedure indication(s), endoscopist, bowel preparation type and quality, and participation by a gastroenterology fellow. Results: 6087 colonoscopies were evaluated in this study. Colonoscopies (n = 3729) performed in the morning were compared to colonoscopies performed in the afternoon (n = 2358). The crude completion rate to the cecum was 95.0% in the morning group while the completion rate to the cecum was 93.6% of the afternoon exams (p = 0.02). The morning colonoscopies had better bowel preparation quality (p < 0.001). The multivariate analyses demonstrated that gender, age, and bowel preparation quality impacted completion rates. After correcting for these factors, there was no significant difference in completion rates in the morning versus afternoon. Conclusion: Uncorrected cecal intubation rates were lower in the afternoon compared to the morning in outpatients undergoing colonoscopy. Bowel preparation quality was worse in the afternoon compared with the morning. Efforts at improving afternoon bowel preparation may improve the outcome of afternoon colonoscopies.
- 8 June 2007
- Published by Springer Nature in BMC Gastroenterology
- Vol. 7 (1) , 1-5
Open AccessComparison of morning versus afternoon cecal intubation rates
Background: Many factors impacting cecal intubation rates have been examined in detail; however, little information exists regarding the effect of the timing of the procedure. We sought to examine any difference in cecal intubation rates between morning and afternoon colonoscopies and identify factors contributing to a discrepancy. Methods: Retrospective, single-center study comparing cecal intubation rates for colonoscopies performed in the morning (begun prior to 12 noon) and colonoscopies performed in the afternoon (begun after 12 noon) over an approximately 12 month period. Univariate and multivariate analyses were performed evaluating patient demographics, procedure indication(s), endoscopist, bowel preparation type and quality, and participation by a gastroenterology fellow. Results: 6087 colonoscopies were evaluated in this study. Colonoscopies (n = 3729) performed in the morning were compared to colonoscopies performed in the afternoon (n = 2358). The crude completion rate to the cecum was 95.0% in the morning group while the completion rate to the cecum was 93.6% of the afternoon exams (p = 0.02). The morning colonoscopies had better bowel preparation quality (p < 0.001). The multivariate analyses demonstrated that gender, age, and bowel preparation quality impacted completion rates. After correcting for these factors, there was no significant difference in completion rates in the morning versus afternoon. Conclusion: Uncorrected cecal intubation rates were lower in the afternoon compared to the morning in outpatients undergoing colonoscopy. Bowel preparation quality was worse in the afternoon compared with the morning. Efforts at improving afternoon bowel preparation may improve the outcome of afternoon colonoscopies.
- 27 September 2005
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 37 (10) , 1060-1064
ICCE Consensus for Esophageal Capsule Endoscopy
Gastroesophageal reflux disease (GERD) and its complications are a common and increasing health-care problem in the developed nations. The National Ambulatory Medical Care Survey 2000, a national survey designed to provide information about the use of ambulatory care services in the United States, revealed that GERD is the second most common diagnosis, resulting in 2.5 million outpatient visits annually [ 1 ]. A publication on selected digestive diseases in the United States suggested that GERD was the third most prevalent disease in the United States with the highest annual direct costs ($ 9.3 billion/year) [ 2 ]. Barrett’s esophagus or specialized intestinal metaplasia (SIM) of the tubular esophagus is a premalignant condition that occurs in approximately 15 % of patients with chronic GERD symptoms and may lead to esophageal adenocarcinoma. Esophageal adenocarcinoma arising from Barrett’s esophagus is the second fastest-increasing cancer in the Western world [ 3 ] [ 4 ] [ 5 ]. In patients with Barrett’s esophagus, the risk of esophageal adenocarcinoma is approximately 0.4 % per patient-year [ 6 ]. Some practice guidelines therefore recommend endoscopic screening for Barrett’s esophagus in patients with chronic GERD [ 6 ]. However, because of the risks, invasiveness, and costs associated with conventional upper endoscopy, screening for Barrett’s esophagus is not uniformly recommended by all experts or clinicians. Erosive esophagitis, esophageal ulcer, stricture, or Barrett’s esophagus are the complications of chronic severe GERD. Approximately 20 - 50 % of patients with GERD are found to have erosive esophagitis. In addition, ulcers or strictures are found in approximately 5 % of GERD patients [ 7 ]. These endoscopic findings have implications for management of GERD patients, in that maintenance antisecretory therapy is recommended by many experts once erosive esophagitis is documented. Upper endoscopy is routinely employed to diagnose GERD and its complications, including esophagitis, stricture, and Barrett’s esophagus. However, endoscopic screening for Barrett’s esophagus is costly and has poor patient compliance. A simple, safe, and less invasive endoscopic procedure for evaluating GERD patients and for screening GERD patients for Barrett’s esophagus may be advantageous. In addition, it is estimated that there are 10 million Americans and untold millions worldwide presently suffering from cirrhosis. Bleeding from esophageal varices is a known complication of portal hypertension, with at least a 20 % mortality associated with each bleeding episode. Prophylactic treatment of varices that have not bled with either band ligation or nonselective beta-blockade has been shown to decrease mortality. National guidelines from the American Association for the Study of Liver Disease (AASLD) and the United Kingdom recommend endoscopic screening of patients with cirrhosis and treatment of patients with medium to large varices to prevent bleeding. Recommended screening intervals are 1 - 3 years, depending on the presence or absence of varices and whether the patient has compensated or decompensated liver disease. Endoscopic surveillance is performed in patients after obliteration of varices. The application of the esophageal capsule endoscope has been considered in this group of patients as well. It has been suggested that this patient population could benefit from a noninvasive diagnostic test that does not require sedation. In addition, patient acceptance of an alternative screening modality could improve adherence to recommendations and appropriate treatment after risk stratification.
- 27 September 2005
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 37 (10) , 1060-1064
ICCE Consensus for Esophageal Capsule Endoscopy
Gastroesophageal reflux disease (GERD) and its complications are a common and increasing health-care problem in the developed nations. The National Ambulatory Medical Care Survey 2000, a national survey designed to provide information about the use of ambulatory care services in the United States, revealed that GERD is the second most common diagnosis, resulting in 2.5 million outpatient visits annually [ 1 ]. A publication on selected digestive diseases in the United States suggested that GERD was the third most prevalent disease in the United States with the highest annual direct costs ($ 9.3 billion/year) [ 2 ]. Barrett’s esophagus or specialized intestinal metaplasia (SIM) of the tubular esophagus is a premalignant condition that occurs in approximately 15 % of patients with chronic GERD symptoms and may lead to esophageal adenocarcinoma. Esophageal adenocarcinoma arising from Barrett’s esophagus is the second fastest-increasing cancer in the Western world [ 3 ] [ 4 ] [ 5 ]. In patients with Barrett’s esophagus, the risk of esophageal adenocarcinoma is approximately 0.4 % per patient-year [ 6 ]. Some practice guidelines therefore recommend endoscopic screening for Barrett’s esophagus in patients with chronic GERD [ 6 ]. However, because of the risks, invasiveness, and costs associated with conventional upper endoscopy, screening for Barrett’s esophagus is not uniformly recommended by all experts or clinicians. Erosive esophagitis, esophageal ulcer, stricture, or Barrett’s esophagus are the complications of chronic severe GERD. Approximately 20 - 50 % of patients with GERD are found to have erosive esophagitis. In addition, ulcers or strictures are found in approximately 5 % of GERD patients [ 7 ]. These endoscopic findings have implications for management of GERD patients, in that maintenance antisecretory therapy is recommended by many experts once erosive esophagitis is documented. Upper endoscopy is routinely employed to diagnose GERD and its complications, including esophagitis, stricture, and Barrett’s esophagus. However, endoscopic screening for Barrett’s esophagus is costly and has poor patient compliance. A simple, safe, and less invasive endoscopic procedure for evaluating GERD patients and for screening GERD patients for Barrett’s esophagus may be advantageous. In addition, it is estimated that there are 10 million Americans and untold millions worldwide presently suffering from cirrhosis. Bleeding from esophageal varices is a known complication of portal hypertension, with at least a 20 % mortality associated with each bleeding episode. Prophylactic treatment of varices that have not bled with either band ligation or nonselective beta-blockade has been shown to decrease mortality. National guidelines from the American Association for the Study of Liver Disease (AASLD) and the United Kingdom recommend endoscopic screening of patients with cirrhosis and treatment of patients with medium to large varices to prevent bleeding. Recommended screening intervals are 1 - 3 years, depending on the presence or absence of varices and whether the patient has compensated or decompensated liver disease. Endoscopic surveillance is performed in patients after obliteration of varices. The application of the esophageal capsule endoscope has been considered in this group of patients as well. It has been suggested that this patient population could benefit from a noninvasive diagnostic test that does not require sedation. In addition, patient acceptance of an alternative screening modality could improve adherence to recommendations and appropriate treatment after risk stratification.
- 1 July 2005
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 39 (6) , 501-507
A Survey of Credentialing Practices of Gastrointestinal Endoscopy Centers in the United States
Competence in gastrointestinal (GI) endoscopy correlates with the number of procedures performed by the endoscopist. For each GI endoscopic procedure, the American Society for Gastrointestinal Endoscopy (ASGE) guidelines recommend minimum numbers needed to assess competence. We conducted an anonymous mail survey to determine whether GI endoscopy centers in the United States follow ASGE or other guidelines for granting and renewing endoscopic privileges. Completed surveys were received from 479 respondents in 46 states, Puerto Rico, and the District of Columbia. Most respondents were either the physician director (24%) or nurse manager (57%) of the endoscopy center. Most centers have more than 5 endoscopists (62%), and gastroenterologists performed procedures in the majority of the centers (89%). For initial endoscopic credentialing, few centers require a minimum number of procedures and only 10% meet ASGE criteria. To maintain credentials, less than one third require a minimum number and only 2% require more than 25 procedures/year. Although three fourths report periodic review of procedures, less than 5% review them more frequently than every 6 months. Only 20% of centers had ever denied endoscopic privileges (poor skills [80%], no references [27%], poor communication [7%], and excess complications [6%]) for which half faced litigation. Most GI endoscopy centers responding to this survey have no minimum standards for determining endoscopic competence and may credential GI endoscopists with suboptimal training. Only 10% adhere to ASGE guidelines. Moreover, there is lack of uniformity to application of these guidelines, and few centers use resulting data to deny or renew credentials. To guarantee high-quality endoscopic practice, more stringent, universal credentialing standards are required.
- 1 July 2005
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 39 (6) , 501-507
A Survey of Credentialing Practices of Gastrointestinal Endoscopy Centers in the United States
Competence in gastrointestinal (GI) endoscopy correlates with the number of procedures performed by the endoscopist. For each GI endoscopic procedure, the American Society for Gastrointestinal Endoscopy (ASGE) guidelines recommend minimum numbers needed to assess competence. We conducted an anonymous mail survey to determine whether GI endoscopy centers in the United States follow ASGE or other guidelines for granting and renewing endoscopic privileges. Completed surveys were received from 479 respondents in 46 states, Puerto Rico, and the District of Columbia. Most respondents were either the physician director (24%) or nurse manager (57%) of the endoscopy center. Most centers have more than 5 endoscopists (62%), and gastroenterologists performed procedures in the majority of the centers (89%). For initial endoscopic credentialing, few centers require a minimum number of procedures and only 10% meet ASGE criteria. To maintain credentials, less than one third require a minimum number and only 2% require more than 25 procedures/year. Although three fourths report periodic review of procedures, less than 5% review them more frequently than every 6 months. Only 20% of centers had ever denied endoscopic privileges (poor skills [80%], no references [27%], poor communication [7%], and excess complications [6%]) for which half faced litigation. Most GI endoscopy centers responding to this survey have no minimum standards for determining endoscopic competence and may credential GI endoscopists with suboptimal training. Only 10% adhere to ASGE guidelines. Moreover, there is lack of uniformity to application of these guidelines, and few centers use resulting data to deny or renew credentials. To guarantee high-quality endoscopic practice, more stringent, universal credentialing standards are required.
- 1 April 2004
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 38 (4) , 326-331
A National Survey of Primary Care Physicians??? Perceptions and Practices Related to Helicobacter pylori Infection
Our aim was to assess current perceptions and practices of primary care physicians in the United States concerning Helicobacter pylori infection. We mailed a structured questionnaire to approximately 2500 primary care physicians chosen at random from a national database. We asked about personal and practice demographics and practices relating to testing for and treating H. pylori infection. We received 424 responses from 2349 questionnaires (18%). Only 3% each had used either the 13C- or 14C-urea breath test; 5% had used the stool antigen test; 92% and 91% recommended testing—and 90% and 82% treatment—for H. pylori in patients with active duodenal and gastric ulcer, respectively. However, only 64% would test for and only 59% would treat H. pylori infection in a patient with past history of duodenal ulcer. Almost half would test patients with gastroesophageal reflux disease being started or maintained on a proton pump inhibitor. The most frequent treatment regimens used were combinations of a proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole. Most respondents had inaccurate information on antibiotic resistance rates for H. pylori. In the absence of symptoms, 26% would personally undergo testing for H. pylori; 30% would be treated if infected. Primary care physicians usually test for and treat H. pylori infection in patients with active ulcer, but fail to do so in patients with a prior history of ulcer. Some test for H. pylori in gastroesophageal reflux disease patients. Most use efficacious treatment regimens, but have inaccurate information on resistance rates.
- 1 April 2004
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 38 (4) , 326-331
A National Survey of Primary Care Physicians??? Perceptions and Practices Related to Helicobacter pylori Infection
Our aim was to assess current perceptions and practices of primary care physicians in the United States concerning Helicobacter pylori infection. We mailed a structured questionnaire to approximately 2500 primary care physicians chosen at random from a national database. We asked about personal and practice demographics and practices relating to testing for and treating H. pylori infection. We received 424 responses from 2349 questionnaires (18%). Only 3% each had used either the 13C- or 14C-urea breath test; 5% had used the stool antigen test; 92% and 91% recommended testing—and 90% and 82% treatment—for H. pylori in patients with active duodenal and gastric ulcer, respectively. However, only 64% would test for and only 59% would treat H. pylori infection in a patient with past history of duodenal ulcer. Almost half would test patients with gastroesophageal reflux disease being started or maintained on a proton pump inhibitor. The most frequent treatment regimens used were combinations of a proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole. Most respondents had inaccurate information on antibiotic resistance rates for H. pylori. In the absence of symptoms, 26% would personally undergo testing for H. pylori; 30% would be treated if infected. Primary care physicians usually test for and treat H. pylori infection in patients with active ulcer, but fail to do so in patients with a prior history of ulcer. Some test for H. pylori in gastroesophageal reflux disease patients. Most use efficacious treatment regimens, but have inaccurate information on resistance rates.